Condition: HLH - Hypoplastic Left Heart Syndrome · DORV · DILV - Double Inlet Left Ventricle · Sponsor: Nationwide Children's Hospital
A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connection.
This description comes directly from the study's public registry record.
Samantha Fichtner, BSN, RN · 614-355-5764 · samantha.fichtner@nationwidechildrens.org
Victoria Shay · victoria.shay@nationwidechildrens.org
Always discuss trial participation with your own doctor first.
| Nationwide Children's Hospital | Columbus, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04467671